MIAT and glioblastoma: The present study employed AGAP2-AS1, SLCO4A1-AS1, HRAT92, PVT1, MIAT, CEROX1 and ENSG00000262223 data in GEPIA dataset to explore its differential expression and effect on GBM prognosis.